Position statement of expert panel of the polish allergology society on the management of patients with bronchial asthma and allergic diseases during SARS-CoV-2 pandemics/ Stanowisko grupy ekspertów polskiego towarzystwa alergologicznego w sprawie postępowania u chorych na astmę i choroby alergiczne w okresie pandemii SARS-CoV-2

The document prepared by the expert panel of allergy/immunology specialists representing Polish Allergy Society intends to provide allergists with recommendations with respect to proper management of allergic patients during SARS-CoV-2 pandemics. Allergist should aim at reducing patient’s social interactions by replacing face-to-face visits with communication via telephone or internet. In parallel allergist is responsible for assuring that the patient is receiving proper care of underlying allergic disease. The experts panel provides eighteen recommendations for management of patients with asthma and allergic diseases during pandemics, indicating that in majority of patients asthma treatment (including inhaled corticosteroids) and allergy treatment should be continued. Specific recommendations for treatment with allergen immunotherapy and with biologics are discussed in details.